Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer
IntroductionColorectal cancer (CRC) is a leading cause of cancer-related mortality globally. Although tumor immunotherapy is widely recognized for treating unresectable CRC, challenges such as ineffective immunotherapy and drug resistance remain prevalent. While intratumor microbiome-derived butyrat...
| Main Authors: | , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Frontiers Media S.A.
2025-01-01
|
| 丛编: | Frontiers in Pharmacology |
| 主题: | |
| 在线阅读: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1510851/full |